Airway eosinophils accumulate in the mediastinal lymph nodes but lack antigen-presenting potential for naive T cells by Rijt, L.S. (Leonie) van et al.
Airway Eosinophils Accumulate in the Mediastinal Lymph Nodes
but Lack Antigen-Presenting Potential for Naive T Cells1
Leonie S. van Rijt,2 Nanda Vos, Danie¨lle Hijdra, Victor C. de Vries, Henk C. Hoogsteden, and
Bart N. Lambrecht
Asthma is characterized by infiltration of the airway wall with eosinophils. Although eosinophils are considered to be effector cells,
recent studies have reported their ability to activate primed Th2 cells. In this study, we investigated whether eosinophils are
capable of presenting Ag to unprimed T cells in draining lymph nodes (DLN) of the lung and compared this capacity with
professional dendritic cells (DC). During development of eosinophilic airway inflammation in OVA-sensitized and challenged mice,
CCR3 eosinophils accumulated in the DLN. To study their function, eosinophils were isolated from the bronchoalveolar lavage
fluid of mice by sorting on CCR3B220CD3CD11cdim low autofluorescent cells, avoiding contamination with other APCs, and
were intratracheally injected into mice that previously received CFSE-labeled OVA TCR-transgenic T cells. Eosinophils did not
induce divisions of T cells in the DLN, whereas DC induced on average 3.7 divisions in 45.7% of T cells. To circumvent the need
for Ag processing or migration in vivo, eosinophils were pulsed with OVA peptide and were still not able to induce T cell priming
in vitro, whereas DC induced vigorous proliferation. This lack of Ag-presenting ability was explained by the very weak expression
of MHC class II on fresh eosinophils, despite expression of the costimulatory molecules CD80 and ICAM-1. This investigation does
not support any role for airway eosinophils as APCs to naive T cells, despite their migration to the DLN at times of allergen
exposure. DC are clearly superior in activating T cells in the DLN of the lung. The Journal of Immunology, 2003, 171: 3372–3378.
A irway mucosal eosinophilia is one of the hallmarks ofallergic asthma. Airway eosinophilia is controlled by al-lergen-specific Th2 cells. In response to Ag presentation
by dendritic cells (DCs),3 Th2 cells release several inflammatory
cytokines inducing adhesion molecules on endothelium and re-
cruiting eosinophils to the inflamed airways (1). Eosinophils are
considered to be terminal effector cells (1–3). By releasing numer-
ous proinflammatory mediators and cytokines as well as cationic
proteins, they damage lung epithelium and account for many of the
histopathologic abnormalities of asthma (4). However, studies
showing expression of MHC class II (MHCII) and the costimula-
tory molecules CD80 and CD86 by eosinophils (5–10) suggested
a possible function as APCs. Ag presentation by eosinophils is getting
more and more consideration. Murine eosinophils derived from bron-
choalveolar lavage (BAL) fluid of sensitized and challenged mice
were reported to stimulate sensitized Th2 cells in vivo, although stim-
ulation was read out ex vivo (7). Eosinophils derived from the peri-
toneal cavity of IL-5-transgenic (Tg) mice were capable of sensitizing
mice after repeated i.p. injections, although the mechanism of T cell
priming was not investigated in a direct manner (8).
As yet no studies have addressed the question whether eosino-
phils obtained from the bronchoalveolar compartment of inflamed
lungs are able to directly activate Ag-specific naive T cells. There-
fore, we investigated the Ag-presenting potential of eosinophils for
naive T cells in vitro and in vivo and compared it with Ag pre-
sentation by professional Ag-presenting DCs. Bronchoalveolar la-
vage fluid (BALF) eosinophils from allergic lungs were isolated
from the lungs of mice with experimental murine asthma using a
new flow cytometric sorting method, based on scatter characteris-
tics and staining for the eotaxin receptor CCR3, at the same time
avoiding contamination with other BALF APCs such as macro-
phages, DCs, and B cells (11, 12). To detect T cell priming in vivo
and in vitro, T cell proliferation was studied in OVA TCR Tg T
cells (DO11.10 T cells) labeled with the mitosis-sensitive dye
CFSE. Our data show that although eosinophils accumulate in the
draining lymph nodes during eosinophilic airway inflammation
and are able to induce some proliferation in effector T cells in vitro,
they are not capable of inducing T cell proliferation in OVA-spe-
cific naive T cells.
Materials and Methods
Animals
All experiments were performed with 8- to 10-wk-old female BALB/c
(H-2d) mice (Harlan, Zeist, The Netherlands) and DO11.10 mice (Erasmus
Medical Center, Rotterdam, The Netherlands). Mice were housed under
specific pathogen-free conditions at the animal care facility at the Erasmus
University Rotterdam. All of the experimental procedures used in this
study were approved by the Erasmus University Committee of Animal
Experiments.
Generation of eosinophilic airway inflammation
To induce sensitization to inhaled OVA, bone marrow-derived DCs were
pulsed with OVA in vitro and subsequently injected into the airways of
naive mice (11). In short, bone marrow cells were cultured for 10 days in
tissue culture medium (5% FCS; Biocell Laboratories, Rancho Dominguez,
CA), RPMI 1640, gentamicin, 2-ME (all from Life Technologies, Paisley,
U.K.) supplemented with 20 ng/ml recombinant murine GM-CSF (13).
After 9 days of culture, cells were pulsed overnight with 100 g/ml OVA
(OVA-DC) (OVA, Worthington Biochemical, Lakewood, NJ). On day 10
of culture, cells were collected, washed, and 1  106 DCs were injected
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intratracheal (i.t.) in naive mice (11), followed 10 days later by a booster
of 10 g OVA absorbed in 1 mg alum adjuvant i.p. injection. Ten days
after boosting, mice were challenged four times with a daily 30-min OVA
aerosol (grade III, 1% w/v in PBS; Sigma-Aldrich, St. Louis, MO).
Flow cytometric analysis on BALF and lymph node eosinophils
Twenty-four hours after the last aerosol, mice were sacrificed by avertin
overdose followed by exsanguination. BAL was performed with 3  1 ml
of Ca2- and Mg2-free PBS supplemented with 0.1 mM EDTA. RBCs
were lysed using ammonium chloride lysis buffer. BALF cells and cell
suspensions of lung draining and nondraining lymph nodes were stained
with the following monoclonals: MHCII-FITC (2G9), allophycocyanin-
labeled CD11c (HL3), and CyChrome-labeled Abs against CD3 (145-
2C11) and B220 (RA3-6B2) and PE-labeled CD80, CD86, ICAM-1 (BD
PharMingen, San Diego, CA), or CCR3 (83101.111; R&D Systems,
Abingdon, U.K.). To prevent a specific binding to FcR, 2.4.G2 blocking
reagent was used. Eosinophils were recognized as nonautofluorescent
highly granular (SSChigh) cells expressing the eotaxin receptor CCR3, in-
termediate levels of CD11c, and very low or lacking expression of MHCII,
B220, and CD3. In indicated experiments, propidium iodide (PI; Sigma-
Aldrich) was used to determine viability of the cells.
Purification and Ag pulsing of airway eosinophils
Eosinophils were purified from BALF under sterile conditions on a FACS
DIVA flow cytometer (BD Biosciences, Mountain View, CA). BALF cells
were stained as described above and eosinophils were recognized and
sorted as nonautofluorescent highly granular (SSChigh) cells expressing the
eotaxin receptor CCR3, intermediate levels of CD11c, and lacking expres-
sion of B220 and CD3. Purity of 96% was determined by H&E staining
on cytospins of sorted eosinophils. Four hundred cells were counted per
cytospin. In some experiments, eosinophils were pulsed ex vivo with 10
g/ml OVA323–339 peptide (Ansynth Service, Roosendaal, The Nether-
lands) for 45 min at 37°C or cultured overnight with or without GM-CSF
(2 ng/ml) in the presence of OVA323–339 peptide. The Ag-presenting ca-
pacity of eosinophils was compared with that of well-known professional
APCs, bone marrow-derived OVA-pulsed DCs grown in GM-CSF as pre-
viously described (11–13).
Ag presentation assay to OVA TCR Tg T cells in vivo
Cell suspensions were made of pooled peripheral lymph nodes (cervical,
mediastinal, brachial, axillary, inguinal, and mesenteric) from DO11.10
mice and were labeled with the mitosis-sensitive dye CFSE (Molecular
Probes, Eugene, OR) as previously described (14). CFSE T cells (10
106) were transferred i.v. into naive mice. Twenty-four hours after T cell
adoptive transfer, either 1  106 purified eosinophils, 1  106 OVA pep-
tide-pulsed eosinophils, or 1  106 OVA-pulsed DCs (11, 12) were trans-
ferred i.t. or 2  106 OVA peptide-pulsed eosinophils i.p. Seventy-two
hours after immunization, lung draining lymph nodes of recipient mice
were analyzed for the proliferation of CFSE-labeled OVA TCR Tg T cells
on a FACSCalibur flow cytometer using FlowJo software (Treestar, Costa
Mesa, CA). As a control, brachial lymph nodes were also harvested to
compare division of T cells in lymph nodes not draining the lung. Trans-
ferred OVA TCR Tg CD4 T cells were recognized as CFSE/
Kj1.26(MM7504; Caltag Laboratories, Burlingame CA)/CD4 cells; PI
(Sigma-Aldrich) was used to exclude dead cells. To prevent a specific
binding to FcR, 2.4.G2 blocking reagent was used.
Ag presentation assay to OVA TCR Tg T cells in vitro
Eosinophils, bone marrow DCs, and OVA TCR Tg T cell suspensions were
prepared as described above. To obtain unstimulated T cells, DO11.10
lymph node cell suspensions were depleted from MHCII, B220, CD11b-
positive cells by Dynal beads (Dynal, Etten-Leur, The Netherlands) to
prevent stimulation by endogenous APCs. To obtain effector T cells,
DO11.10 lymph node suspensions were cocultured with OVA-pulsed DCs
for 2 wk; fresh DCs were added after 1 wk. After 2 wk, CD4 cells were
isolated using a negative CD4 T cell isolation kit for the auto-MACS
(Miltenyi Biotec, Gladbach, Germany) with a purity of 99%, of which 75%
had an effector T cell phenotype (CD62Llow/CD44high). The kit was used
according to the manufacturer’s instructions. Cells were rested overnight in
50 U/ml recombinant human IL-2 (PeproTech, Rocky Hill, NJ) before
coculture with eosinophils. Fifty thousand CFSE unstimulated or effector
T cells were cocultured with 1  103, 1  104, or 1  105 either unpulsed
or peptide-pulsed eosinophils in comparison to 1  103, 1  104, or 1 
105 bone marrow-derived OVA-pulsed or unpulsed DCs. Seventy-two
hours later, stimulation of naive T cells or effector T cells was analyzed by
staining cocultures with Kj1.26-PE and CD4-APC; PI was used to exclude
dead cells. To prevent a specific binding to FcR, 2.4.G2 blocking reagent
was used.
Results
OVA exposure induces accumulation of eosinophils in BALF
and lung draining lymph nodes of OVA DC-immunized mice
Sensitization was induced by i.t. injection of 1  106 OVA-pulsed
DCs, followed by a booster of OVA/alum i.p. 10 days later. Sen-
sitized mice were challenged with four OVA aerosols. Mice were
sacrificed 24 h after the last challenge. Differential analysis of
BALF cells showed a distinct increase in eosinophils. Using flow
cytometry, several markers were used to determine eosinophils in
BALF. Eosinophils were characterized as nonautofluorescent
highly granular (SSChigh) cells expressing intermediate levels of
CD11c and lacking expression of B220 and CD3, as described
previously (12) (see also Fig. 3). These highly granular cells also
expressed the eotaxin receptor CCR3 (15). Average percentage of
eosinophils in BALF after challenge was 40–70%. In addition to
the induced eosinophilic airway inflammation, also other hall-
marks were induced as goblet hyperplasia and Th2 cytokine pro-
duction by draining lymph nodes (data not shown).
To investigate whether airway inflammation increased the num-
ber of eosinophils in the draining lymph nodes of the lung, where
APCs present Ag to naive T cells, lymph nodes were collected,
homogenized, and analyzed for the presence of CCR3 eosino-
phils. Draining lymph nodes of the inflamed lungs showed an in-
creased number of eosinophils compared with lymph nodes not
draining the lungs and to lung draining lymph nodes from naive
animals (3.6  104 vs, respectively, 246 ( p  0.008) and 52 ( p 
0.008; Fig. 1).
To determine whether eosinophils in the bronchoalveolar com-
partment are expressing the molecules needed to prime T cells,
FIGURE 1. Accumulation of CCR3 eosinophils in draining lymph
nodes of the lung. Mice were immunized on day 0 with 1  106 OVA-
pulsed DCs and received an OVA/alum booster injection at day 10. At days
20–23, they were challenged daily for 30 min with OVA aerosols. A and
B, Ungated forward scatter (FSC)/side scatter (SSC) plots of cell suspen-
sions of draining or nondraining lung lymph nodes of OVA-sensitized and
challenged mice showing the presence of highly granular (SSChigh) cells. A
gate was set on these cells (C). Within the same gate, these granular cells
expressed CCR3 and very weakly MHCII (open histograms). Staining by
isotype control IgG2a is indicated by the filled histogram. D,
CCR3MHCIIlow eosinophils accumulated in draining lymph nodes of the
lung and not in nondraining lymph nodes.
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eosinophils from allergically inflamed lungs were examined for the
expression of MHCII, costimulatory molecules CD80 and CD86,
and ICAM-1. Eosinophils showed a very weak expression of
MHCII and a distinct expression of CD80 and ICAM-1, but had a
minimal expression of CD86 (Fig. 2)
Intratracheal injection of BALF eosinophils does not prime
naive OVA TCR Tg T cells in vivo
As eosinophils accumulated in the draining lymph nodes at times
of eosinophilic inflammation and expressed the molecules neces-
sary for T cell interaction, we speculated that they might be pre-
senting Ag to OVA-specific T cells. To investigate this further,
eosinophils were purified from BALF of sensitized and challenged
mice based on characteristics described above. Using this method,
a distinction could be made between eosinophils and other (pos-
sible) APCs in BALF (Fig. 3) e.g., B cells (Fig. 3E, B220high
MHCIIhigh), macrophages (Fig. 3F, large autofluorescent cells),
and DCs (Fig. 3D, nonautofluorescent CD11chighMHCIIhigh cells)
(12). Purity of sort was determined by immunocytochemical stain-
ing on cytospins of sorted eosinophils identifying eosinophils by
their donut-shaped nucleus and eosin staining of cytoplasm (Fig.
4B). After sorting, a purity of 96% was achieved based on flow
cytometry and differential cell counts on cytospins (Fig. 4). Puri-
fied in vivo-pulsed eosinophils were injected into the trachea of
naive mice. Viability of these transferred cells was determined by
flow cytometry 3 days after instillation. A distinct CCR3 eosino-
phil population could be observed in the BAL compartment, which
was PI negative, indicative of viable cells. (20.4% eosinophils of
total BAL cells vs 0.7% after OVA-pulsed DC instillation and
0.5% after unpulsed DC instillation) (Fig. 5). Mice received a co-
hort of CFSE plus OVA TCR Tg T cells by i.v. injection 1 day
before i.t. injection of purified in vivo-pulsed eosinophils. BALF
eosinophils from allergic mice did not induce divisions of naive T
cells in contrast to OVA-pulsed DCs, which induced vigorous T
cell division (Fig. 6A).
The lack of T cell division after injecting eosinophils obtained
from OVA-induced airway inflammation could be due to insuffi-
cient uptake of OVA by eosinophils in vivo. To investigate
whether eosinophils were able to present processed OVA peptide
to naive OVA TCR Tg T cells in vivo, bypassing the need for Ag
uptake and processing, eosinophils were pulsed in vitro with OVA
peptide after sorting. Intratracheal injection of in vitro-pulsed eo-
sinophils in mice that received CFSE T cells i.v. did not induce
divisions (Fig. 6B). The absence of T cell division was not due to
a lack of responsiveness of our T cells as i.t. injection of DCs
induced an average of 3.7 divisions in 45.7% of the T cells.
To exclude the possibility that eosinophils from the BALF were
incapable of priming naive T cells because of their inability to
migrate to the draining lymph nodes, 2  106 peptide-pulsed eo-
sinophils were injected i.p. because i.p. injection of cells leads to
localization of cells in the thoracic lymph nodes by peritoneal
drainage (16). Eosinophils still did not induce divisions of T cells
when injected i.p. (Fig. 6C).
BALF eosinophils do not prime naive OVA TCR Tg T cells in
vitro in contrast to effector T cells
To investigate the Ag-presenting capacity of eosinophils in direct
contact with OVA TCR Tg T cells, 5  104 CFSE MHCII
B220CD11b unstimulated T cells were cocultured with 1 
103, 1  104, or 1  105 fresh in vivo-pulsed BALF eosinophils
or in vitro OVA-pulsed eosinophils (Fig. 7B, i-vi). After 72 h, no
FIGURE 2. Expression of molecules associated with Ag presentation
on BALF eosinophils. Eosinophils were recognized as highly granular, low
autofluorescent cells that lacked expression of CD3 and B220. Staining
revealed a very low expression of MHCII, a distinct expression of CD80
and ICAM-1, and a minimal CD86 expression. Staining by isotype control
Abs is expressed as filled histograms.
FIGURE 3. Isolation of BALF eosinophils without contamination of
other APCs. BALF cells of OVA-sensitized and challenged mice were
stained to isolate eosinophils (EO) using flow cytometry. A, The forward
scatter (FSC)/side scatter (SSC) plot of ungated BALF cells contains gran-
ulocytes (G1) and lymphocytes (L) and macrophages (M). B, By staining
with B220 and CD3, several BALF cell populations could be discrimi-
nated. Gates were set on these populations and analyzed further by addi-
tional staining or by scatter characteristics. Used gates are displayed in the
upper right corner. C, To isolate eosinophils, a gate was set on low
autofluorescent cells that lacked expression of CD3 and B220 (G2). Within
this gate, CCR3 expression made it possible to distinguish eosinophils.
BALF eosinophils expressed MHCII very weakly. D, Other APCs could be
identified as MHCIIhighCD11chigh cells representing DCs (B and D),
whereas B cells can be identified in the L gate from T cells as MHCIIhigh
(B and E), and alveolar macrophages (M) as large and spontaneously
autofluorescent cells (B and F).
3374 EOSINOPHILS AS APCs
divisions of T cells were induced. In contrast, OVA-pulsed DCs
induced a vigorous proliferation of 80% of T cells with an average
of 3.8 divisions. (Fig. 7A).
Eosinophils are reported to present Ag to already sensitized T
cells (7, 8). To investigate whether BALF eosinophils do have the
capacity of stimulating sensitized T cells, 1 103, 1 104, or 1
105 fresh in vivo-pulsed BALF eosinophils or in vitro OVA-pulsed
eosinophils were cocultured with effector CD62LlowCD44high
OVA TCR Tg T cells that were obtained by in vitro stimulation by
OVA-pulsed DCs. Both in vivo- and ex vivo-pulsed eosinophils
were able to induce some proliferation in effector T cells but not as
vigorous as that induced by OVA-pulsed DCs (Fig. 8B: resp. 1
APC: 5 T cells: 16.9 and 16.1% compared with 88.5% by DCs, 2
APC: 1 T cell: 31.4 and 37.8% compared with 70% by DCs).
Experiments with or without adding 5 ng/ml GM-CSF to the cul-
ture medium yielded similar proliferation results (data not shown).
T cells cultured without APCs did not divide (Fig. 8).
Expression of molecules associated with Ag presentation on
BALF eosinophils after stimulation with GM-CSF
Since naive T cell priming was not properly induced by freshly
sorted eosinophils in vitro or in vivo, eosinophils were incubated
overnight with GM-CSF to enhance Ag-presenting capacities as
shown by others. We sorted CCR3 eosinophils from lavage fluid
of sensitized and challenged mice and incubated these cells for 1
day with GM-CSF before culture with CFSE-labeled OVA TCR
Tg T cells in the presence or absence of in vitro OVA peptide
pulsing. Eosinophils cultured in GM-CSF did not differ in MHCII
staining compared with eosinophils cultured in medium and ac-
cordingly failed to induce T cell division readily observed follow-
ing stimulation with DCs (data not shown). No difference in via-
bility between eosinophils cultured with or without GM-CSF was
observed, both conditions yielded 99% PI viable eosinophils
after culture with T cells (data not shown).
Discussion
For several years, it has been described that eosinophils are able to
express MHCII and costimulatory molecules and are able to mi-
grate to the draining lymph node T cell area, suggesting that they
FIGURE 5. Viability of eosinophils from BALF after i.t. injection.
Sorted eosinophils were injected i.t. in naive mice and 3 days later, lack of
PI uptake by BALF eosinophils was determined as a marker for viability.
A, Eosinophils were identified as CCR3highMHCIIlow cells in the granulo-
cyte gate and were all low in PI uptake, indicative of viable cells. By
contrast, mice that received 1  106 OVA-DCs had no eosinophils in the
BALF (B) EO, eosinophil.
FIGURE 4. Sorting eosinophils from BALF. Cells were sorted as
CCR3, low autofluorescent CD3B220 cells as described in Fig. 3. A,
Left, MHCII vs CCR3 on ungated cells before sorting. Right, MHCII vs
CCR3 on ungated cells after sorting. B, Cytospins of unsorted and sorted
populations were analyzed for the number of eosinophils identified by an
eosinophilic cytoplasm and a donut-shaped nucleus. Left, Sixty-five per-
cent of cells were identified as eosinophils before sort; right, 96% of cells
were identified as eosinophils after sort.
FIGURE 6. Ag presentation assay in vivo. Ag-presenting capacity of
eosinophils was investigated by injecting eosinophils i.t. in mice that re-
ceived CFSE-labeled OVA TCR Tg T cells i.v. 1 day earlier. Division of
T cells induced by eosinophils was determined by FACS analysis (filled
histograms). OVA-pulsed bone marrow-derived DCs were used as control
APCs (open histograms). A, Eosinophils exposed to OVA in vivo by aero-
sols were not capable of inducing proliferation of naive T cells. B, Expos-
ing eosinophils in vitro to OVA peptide, avoiding the need for Ag capture
and processing, still did not induce priming capability for naive T cells in
eosinophils. C, Intraperitoneal injection of OVA peptide-exposed eosino-
phils did not prime naive T cells. Plots shown are representative of multiple
experiments with four to eight mice per group.
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might be endowed with Ag-presenting capacity. In our experi-
ments, an accumulation of CCR3 eosinophils in draining lymph
nodes of the lung was indeed observed at a time point when eo-
sinophils were accumulating in the allergically inflamed lung, sug-
gesting that eosinophils were migrating from the lung to the lymph
nodes where T cells are recirculating. These findings are consistent
with earlier reports by other groups and indeed suggest some Ag-
presenting function (7–10). In our study, in addition to the pres-
ence of eosinophils at the site of T cell encounter, BALF eosino-
phils weakly expressed MHCII and expressed high levels of
costimulatory molecules CD80 and ICAM-1. Functional studies
have been performed to investigate Ag presentation of BALF eo-
sinophils, but these studies focused mainly on the stimulation of
polyclonal primed T cells and did not directly address T cell ac-
tivation in vivo (7, 8).
This stimulation of primed T cells by eosinophils led us to in-
vestigate whether eosinophils obtained from an inflammatory site
were capable of sensitizing naive Ag-specific T cells in vivo. We
isolated eosinophils from the bronchoalveolar compartment of the
inflamed lungs of OVA-sensitized and challenged mice (12, 14).
Isolated eosinophils that were exposed to OVA Ag by aerosol
exposures in vivo were introduced in the airways of naive mice
that received CFSE-labeled OVA TCR Tg T cells i.v. 1 day earlier.
Eosinophils injected into the airway lumen have been shown to
reach the T cell area of the draining nodes of the lung (7). The
adoptive transfer of CFSE-labeled Ag-specific T cells enabled us
to investigate the Ag-presenting capacity of eosinophils to
unprimed Ag-specific T cells in the draining lymph nodes of the
lung by visualizing the number of T cell divisions in vivo (14).
This system is extremely sensitive in detecting the presence of
APCs. After 3 days, there was no induction of proliferation of T
cells in the draining lymph nodes of the lung while OVA-pulsed
DCs, injected i.t. as a positive control, induced proliferation in
45.7% of T cells, some cells reaching six to seven divisions. The
absence of T cell priming was not due to the death of transferred
eosinophils, as 20.4% of total BALF cells were viable eosinophils.
One possible explanation for the lack of T cell priming could be
that eosinophils from the BALF were not capable of capturing and
processing sufficient OVA. To bypass the need for Ag uptake and
processing, eosinophils were pulsed with OVA peptide in vitro.
Intratracheally injecting in vitro-pulsed eosinophils still did not
induce any divisions of OVA TCR Tg T cells. Still, these findings
cannot exclude that eosinophils might have some Ag-presenting
function. Isolated BALF eosinophils injected into the trachea had
to migrate from the trachea through the epithelial barrier toward
draining lymph nodes to sensitize naive T cells. Since the migra-
tion potential of eosinophils might be lower in noninflamed lungs,
FIGURE 7. In vitro eosinophil Ag-presenting capacity to naive T cells
(B). In vivo OVA aerosol exposed (indicated by unpulsed: i, iii, and v)- and
in vitro OVA peptide-exposed eosinophils (indicated by pulsed: ii, iv, and
vi) were cocultured with 50,000 naive T cells. Eosinophils (EOs) were
added in different concentrations to naive T cells: 1  103,1  104, or 1 
105. With up to two eosinophils per naive T cells, there was still no pro-
liferation of naive T cells (v and vi). A, Bone marrow-derived DCs induced
in 80% of T cells an average of 3.8 divisions only when DC were pulsed
with OVA.
FIGURE 8. In vitro eosinophil Ag-presenting capacity to effector T
cells Effector CD62LlowCD44high OVA TCR Tg T cells (5  104 cells/
well) obtained in vitro by OVA DC stimulation of naive OVA-specific T
cells were cocultured with 0, 1  103, 1  104, or 1  105 freshly isolated
eosinophils (EOs) from BALF of OVA-sensitized and challenged mice. A,
Left, A gate was set around Kj1.26 T cells cultured without APCs after
gating on PICD4cells to define undivided T cells. Right, Divided T cells
were defined as Kj1.26 cells with low CFSE content. The limit to define
undivided T cells was set on the CFSE content of unstimulated T cells. B,
Eosinophils were either pulsed in vivo by OVA aerosols or ex vivo by
OVA peptide pulsing followed by vigorous washing. Ex vivo- and in vivo-
pulsed eosinophils were both able to induce some proliferation at a ratio of
one or two eosinophils per effector T cells but induced proliferation in a
lesser degree than OVA-pulsed DCs. Effector T cells cultured without any
APCs did not divide.
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an alternative route of injection was chosen in our studies. Material
injected in the peritoneal cavity is drained nonspecifically to the
thoracic lymph nodes (16). Therefore, we injected sorted OVA
peptide-pulsed eosinophils i.p. to allow eosinophils to reach the
draining lymph nodes, but still observed no divisions in Ag-spe-
cific T cells.
Finally, to exclude that the number of eosinophils encountering
naive T cells was not sufficient to induce priming and to exclude
that absence of migration was causing the absence of T cell acti-
vation, T cells were cultured in vitro with sorted eosinophils in a
very high stimulator to the responder setting. In vitro data were in
accordance with in vivo data, showing no Ag presentation despite
these permissive conditions of naive T cell activation. In contrast,
a proliferation of naive T cells by OVA-pulsed DCs was almost
80% of T cells in vitro (compared with 45.7% of T cells in vivo)
at very low stimulator:responder ratios. To verify whether these
eosinophils were capable of some Ag presentation, eosinophils
were also cocultured with in vitro-obtained effector OVA-specific
T cells. These eosinophils were capable of stimulating effector T
cells, in accordance with other studies (7), although less strongly
than proliferation induced by professional Ag-presenting DCs. To-
gether these data suggest that freshly isolated eosinophils from the
BAL compartment have no evident Ag-presenting capacity for na-
ive T cells, whereas professional Ag-presenting DCs are clearly
able to activate unstimulated T cells.
What then might be the explanation for this lack of APC func-
tion to naive T cells while at the same time eosinophils induced
some proliferation in primed T cells? In accordance with other
studies, the isolated BALF eosinophils used in this study expressed
CD80 and ICAM-1 involved in T cell costimulation (7). However,
they consistently expressed MHCII at very low levels in the bron-
choalveolar compartment where the lung encounters inhaled Ag
and did not up-regulate MHCII following their migration to the
draining nodes or after overnight culture with or without GM-CSF.
Naive T cells have more stringent requirements for signal 1 and
signal 2 compared with effector T cells, which might explain the
difference.
There are some conflicting data about MHCII expression by
eosinophils. In humans, expression of the molecules for T and B
cell interactions was only reported on eosinophils in allergen-chal-
lenged airways, but not on activated blood eosinophils (6, 17, 18).
An explanation for this phenomenon could be that cytokines se-
creted by allergic lung cells could up-regulate MHCII expression
on eosinophils. Several cytokines like IFN-, IL-3, and GM-CSF
secreted by inflammatory cells are reported to induce MHCII ex-
pression in vitro (5, 17, 19). In support of this, eosinophils from the
peritoneal cavity of IL-5 Tg mice that were purified using Percoll
gradients and adherence steps were reported to have no MHCII
expression, except when cultured with GM-CSF (19). Others
showed that BALF eosinophils isolated using Percoll gradients and
adherence culture weakly expressed MHCII, probably because of
GM-CSF release in vivo (7). This is unlikely in our studies, as we
have shown in previous experiments that GM-CSF levels in BAL
are below detection limit (12). Similarly, eosinophils from BALF
isolated based on forward and side scatter characteristics and light
polarization were reported to have a low expression of MHCII,
although at higher levels than on the eosinophils described in this
study (8). In all of these studies, eosinophils were first purified
using extensive protocols, before MHCII staining was performed,
suggesting that MHCII might have been up-regulated ex vivo. In
our hands, fresh eosinophils in lavage fluid, identified based on
scatter characteristics and CCR3 staining, had a very weak MHCII
expression that was only able to stimulate effector T cells in very
high stimulator:responder ratios. Culture of highly purified BALF
eosinophils, specifically in GM-CSF, did not enhance MHCII ex-
pression (data not shown). Perhaps the isolation method can at-
tribute for the difference found in MHCII expression.
Others have demonstrated T cell stimulation of primed poly-
clonal T cells by peritoneal eosinophils and alveolar eosinophils in
vitro. Proliferation of primed T cells in vitro was only induced by
eosinophils stimulated with GM-CSF and not by directly isolated
eosinophils (7, 19). In this study, we confirmed these findings us-
ing OVA-specific TCR Tg T cells and showed that freshly isolated
BALF eosinophils were able to induce some proliferation in ef-
fector T cells but less strongly compared with professional DCs
(Fig. 8).
We took great care to isolate eosinophils without contamination
of other APCs. We developed a new more accurate purification
method. By using flow cytometric scatter characteristics, multiple
positive and negative markers, and taking advantage of the
autofluorescence of macrophages, it was possible to sort CCR3
eosinophils while avoiding B cells, T cells, macrophages, and
DCs, preventing contamination with these APCs (12, 15). In this
study, Ag presentation of CCR3 purified eosinophils from the
BALF to naive T cells was investigated directly in vitro and in
vivo with a very sensitive readout, using naive OVA TCR Tg T
cells labeled with CFSE, showing no direct Ag presentation. One
other study has also investigated the potential of eosinophils to
induce priming in a naive setting. In this study, eosinophils from
the peritoneal cavity of IL-5 Tg mice were capable of sensitizing
mice when injected repeatedly in the peritoneal cavity. After sub-
sequent challenge with OVA aerosols, eosinophilia could be ob-
served, and thus it was concluded that eosinophils induce T cell
responses to OVA (8). These studies did not directly address when
and how T cell priming occurred however. One possibility could
be that repeated injection of Ag-carrying eosinophils led to uptake
of Ag by endogenous professional APCs such as DCs. DCs have
been shown to capture Ag from apoptotic cells, leading to Ag
presentation to naive CD4 and CD8 T cells (20). Moreover, in-
jected IL-5 Tg eosinophils in the peritoneum reach the thoracic
lymph nodes by nonspecific drainage (16) or specific migration,
introducing a source of IL-5 to the site of challenge. This higher
level of IL-5 production in the lung could have lowered the thresh-
old for development of eosinophilic airway inflammation induced
by eosinophil immunization and/or subsequent OVA challenge, as
Il-5 is known as an important chemoattractant and differentiation
factor for eosinophils (1).
If eosinophils do not seem to activate naive T cells in the drain-
ing nodes, what then might be the role of eosinophil accumulation
in the lung draining lymph nodes of allergic mice? One possibility
would be that they stimulate already primed T cells (7, 8) and not
naive T cells. It has been shown that the requirements for naive T
cell activation are more stringent than for primed T cells, and
indeed the very low MHCII expression level in our model did not
induce proliferation in naive T cells but allowed induction of some
proliferation of effector T cells, although not as strongly as pro-
fessional DCs. Alternatively, eosinophils might indirectly effect
Ag presentation by DCs by secreting cytokines and mediators.
Studies that have used anti-IL-5 to eliminate eosinophils system-
ically from the body have however observed no obvious change in
the levels of Th2 cytokine secretion in draining nodes or effector
site, arguing against an absolute requirement for eosinophils in the
stimulation of primed Th2 cells (21).
Together these data imply that although eosinophils accumulate
in the draining nodes at times of eosinophilic airway inflammation
and do express CD80, ICAM-1, and very low levels of MHCII,
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they do not present Ag to naive T cells. These results do not di-
minish their evident role as effector cells in asthma. Further elu-
cidation of the most important aspects of eosinophil biology in
ongoing airway inflammation is necessary to develop an effective
intervention therapy targeted to these cells.
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